Successful migraine prophylaxis with naproxen sodium

Area of Science:

• Neurology
• Pharmacology

Background:

• Migraine is a common neurological disorder characterized by severe headaches.
• Prostaglandin inhibition and platelet aggregation are key mechanisms in migraine pathophysiology.

Purpose of the Study:

• To evaluate the efficacy of naproxen sodium in migraine prophylaxis.
• To compare naproxen sodium with placebo in a randomized, double-blind, controlled trial.

Main Methods:

• A randomized, double-blind, placebo-controlled, crossover trial was conducted.
• Patients received either naproxen sodium or placebo for migraine prevention.
• Efficacy was assessed through patient diaries, monitoring headache severity, associated symptoms, and medication use.

Main Results:

• 52% of patients experienced no severe headaches on naproxen sodium, versus 19% on placebo.
• Naproxen sodium demonstrated superior outcomes in reducing headache severity, nausea, vomiting, and activity reduction.
• Platelet inhibition levels did not correlate with headache prevention efficacy.

Conclusions:

• Naproxen sodium is highly effective for migraine prevention.
• It can be recommended as a first-choice drug for individuals seeking migraine prophylaxis.